3-{3-Pyridin-3-ylmethyl-5-[2-(pyrrolidine-1-sulfonylamino)-ethyl]-phenyl}-propionic acid

ID: ALA326356

PubChem CID: 10502084

Max Phase: Preclinical

Molecular Formula: C21H27N3O4S

Molecular Weight: 417.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CCc1cc(CCNS(=O)(=O)N2CCCC2)cc(Cc2cccnc2)c1

Standard InChI:  InChI=1S/C21H27N3O4S/c25-21(26)6-5-17-12-18(7-9-23-29(27,28)24-10-1-2-11-24)14-20(13-17)15-19-4-3-8-22-16-19/h3-4,8,12-14,16,23H,1-2,5-7,9-11,15H2,(H,25,26)

Standard InChI Key:  BSTJPYNZDQCBNL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0125    0.5875    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7083    0.1833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4167   -0.1250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4000    1.3083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2875    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7292    0.9958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2417   -2.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1375    0.4375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9542   -3.1917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5542   -0.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8625    0.5333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2750   -0.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5792    0.9333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0042    0.8958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8417   -0.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2500   -1.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5375   -1.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5292   -3.1875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7167    0.4708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4292    0.5708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4708    0.5333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8125   -0.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4292    0.8708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1542    0.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1250   -0.3792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6917   -0.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6208   -0.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0250   -0.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4042   -0.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  2  0
  4  1  2  0
  5 13  1  0
  6  1  1  0
  7 16  1  0
  8 23  1  0
  9  7  2  0
 10 15  2  0
 11 24  1  0
 12 10  1  0
 13 11  2  0
 14  5  1  0
 15 11  1  0
 16 17  1  0
 17 10  1  0
 18  7  1  0
 19 14  1  0
 20  6  1  0
 21  2  1  0
 22  2  1  0
 23 19  2  0
 24 20  1  0
 25 29  1  0
 26 19  1  0
 27 22  1  0
 28 21  1  0
 29 26  2  0
 27 28  1  0
  5 12  2  0
 25  8  2  0
M  END

Associated Targets(Human)

TBXAS1 Tchem Thromboxane-A synthase (3355 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tbxa2r Thromboxane A2 receptor (199 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 417.53Molecular Weight (Monoisotopic): 417.1722AlogP: 2.16#Rotatable Bonds: 10
Polar Surface Area: 99.60Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 4.09CX Basic pKa: 5.43CX LogP: 0.96CX LogD: -0.79
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.62Np Likeness Score: -0.81

References

1. Dickinson RP, Dack KN, Long CJ, Steele J..  (1997)  Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.,  40  (21): [PMID:9341919] [10.1021/jm9702793]

Source